OSE Immunotherapeutics SA (EPA:OSE)
France
· Delayed Price · Currency is EUR 3.146
+0.096 (3.15%)
Jun 26, 2026, 5:35 PM CET
OSE Immunotherapeutics Employees
OSE Immunotherapeutics had 64 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
64
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
€42,047
Profits / Employee
€588,891
Market Cap
73.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ABIONYX Pharma | 49 |
| Adocia | 73 |
| Valerio Therapeutics Société anonyme | 25 |
| MaaT Pharma | 59 |
| Fermentalg | 64 |
| Sensorion | 63 |
| THX Pharma Société Anonyme | 12 |
| Innate Pharma | 164 |
OSE Immunotherapeutics News
- 17 days ago - OSE Immunotherapeutics Transcript: Status update - Transcripts
- 24 days ago - OSE Immunotherapeutics Reports Full Year 2025 Audited Consolidated Financial Results and Announces the Filing of its 2025 Universal Registration Document - GlobeNewsWire
- 4 weeks ago - OSE Immunotherapeutics to Implement a Flexible Bridge Equity Financing - GlobeNewsWire
- 5 weeks ago - OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer - GlobeNewsWire
- 2 months ago - OSE Immunotherapeutics Reports Full Year 2025 Unaudited Consolidated Financial Results and 2026 Q1 Cash Position - GlobeNewsWire
- 2 months ago - OSE Immunotherapeutics Earnings release: H2 2025 - Filings
- 2 months ago - OSE Immunotherapeutics Annual report: H2 2025 - Filings
- 2 months ago - OSE Immunotherapeutics Welcomes FDA Orphan Drug Designation Granted to Pegrizeprument (VEL-101) for Prevention of Organ Rejection in Heart Transplant Patients - GlobeNewsWire